{"id":15957,"date":"2014-02-25T10:01:20","date_gmt":"2014-02-25T15:01:20","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=15957"},"modified":"2014-02-25T09:08:40","modified_gmt":"2014-02-25T14:08:40","slug":"on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo-15957","title":{"rendered":"On The Spotlight: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR), Yahoo! Inc. (NASDAQ:YHOO)"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 02\/25\/2014 (wallstreetpr) &#8211;<b> <\/b><b>Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) <\/b>releases its fiscal 2013 fourth quarter early morning Tuesday, February 25. The company is expected to report earnings of (47 cents) per share. Revenue is expected to come in at $6.31 million. These are estimates issued by analysts tracking the stock. ARIA has a consensus \u201chold\u201d rating and average price objective of $7.36 as result of 23 analysts tracking the ticker. The stock of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) lost 2.71 percent in the last session, leading the share to close at $8.63.<\/p>\n<p style=\"text-align: justify;\"><b>Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR)<\/b> could end up posting record earnings in the latest quarter when it reports Tuesday, February 25. The most indebted oil company is forecast to report higher quarterly earnings due to the support of fuel price increase as was granted by the government. Such increases in fuel prices help to reduce refining losses. The new fuel prices which took effect in November reflected increases of 4 and 8 percent on the prices of gasoline and diesel respectively. That was the first time in nine months that PBR was allowed to adjust its fuel prices upwards. But even with that price hike, the company continued selling its fuel at a price that was 11 percent below the global price through the fourth quarter. That is according to estimates issued by Deutsche Bank SA. The stock of Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) gained 2.1 percent in the last session, sending the shares to perch at $11.67.<\/p>\n<p style=\"text-align: justify;\"><b>Yahoo! Inc. (NASDAQ:YHOO)<\/b> has announced that its chief financial officer Ken Goldman will present at the upcoming JMP Securities conference. The company stated that Mr. Goldman will participate in question-answer session on March 3 at the JMP Securities Technology Conference. The event will take place in San Francisco, starting 11:30 a.m. PT. That is equivalent to 2:30 p.m. ET. The company is also reportedly scouting for some fresh minds to join its board as independent directors. CEO Marissa Mayer is reportedly drilling down to get people she knows well. Shares of Yahoo! Inc. (NASDAQ:YHOO) rose 0.35 percent by bell time to perch at 37.42. That gained followed news that the company was making its news summary service available in the U.K.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 02\/25\/2014 (wallstreetpr) &#8211; Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) releases its fiscal 2013 fourth quarter early morning Tuesday, February 25. The company is expected to [&hellip;]<\/p>\n","protected":false},"author":13,"featured_media":14450,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[2236],"tags":[2780,2781,709,1884,1883,1816],"stock_ticker":[],"class_list":["post-15957","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-ariad-pharmaceuticals-inc-nasdaqaria","tag-nasdaqaria","tag-nasdaqyhoo","tag-nysepbr","tag-petroleo-brasileiro-petrobras-sa-adr-nysepbr","tag-yahoo-inc-nasdaqyhoo","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>On The Spotlight: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR), Yahoo! Inc. (NASDAQ:YHOO) - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo-15957\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"On The Spotlight: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR), Yahoo! Inc. (NASDAQ:YHOO) - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 02\/25\/2014 (wallstreetpr) &#8211; Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) releases its fiscal 2013 fourth quarter early morning Tuesday, February 25. The company is expected to [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo-15957\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-02-25T15:01:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Ariad-Pharmaceuticals-Inc.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"709\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lisa Ray\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lisa Ray\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo-15957#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo-15957\"},\"author\":{\"name\":\"Lisa Ray\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c\"},\"headline\":\"On The Spotlight: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR), Yahoo! Inc. (NASDAQ:YHOO)\",\"datePublished\":\"2014-02-25T15:01:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo-15957\"},\"wordCount\":380,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo-15957#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Ariad-Pharmaceuticals-Inc.jpg\",\"keywords\":[\"Ariad Pharmaceuticals Inc. (NASDAQ:ARIA)\",\"NASDAQ:ARIA\",\"NASDAQ:YHOO\",\"NYSE:PBR\",\"Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR)\",\"Yahoo! Inc (NASDAQ:YHOO)\"],\"articleSection\":[\"Business\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo-15957#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo-15957\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo-15957\",\"name\":\"On The Spotlight: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR), Yahoo! Inc. (NASDAQ:YHOO) - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo-15957#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo-15957#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Ariad-Pharmaceuticals-Inc.jpg\",\"datePublished\":\"2014-02-25T15:01:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo-15957#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo-15957\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo-15957#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Ariad-Pharmaceuticals-Inc.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Ariad-Pharmaceuticals-Inc.jpg\",\"width\":1024,\"height\":709},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo-15957#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"On The Spotlight: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR), Yahoo! Inc. (NASDAQ:YHOO)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c\",\"name\":\"Lisa Ray\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png\",\"caption\":\"Lisa Ray\"},\"description\":\"Lisa has a Bachelor of Arts in journalism from Purdue University and 3 years of experience in the publishing field.\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/linsay-thomas\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"On The Spotlight: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR), Yahoo! Inc. (NASDAQ:YHOO) - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo-15957","og_locale":"en_US","og_type":"article","og_title":"On The Spotlight: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR), Yahoo! Inc. (NASDAQ:YHOO) - Wall Street PR","og_description":"Boston, MA 02\/25\/2014 (wallstreetpr) &#8211; Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) releases its fiscal 2013 fourth quarter early morning Tuesday, February 25. The company is expected to [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo-15957","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-02-25T15:01:20+00:00","og_image":[{"width":1024,"height":709,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Ariad-Pharmaceuticals-Inc.jpg","type":"image\/jpeg"}],"author":"Lisa Ray","twitter_misc":{"Written by":"Lisa Ray","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo-15957#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo-15957"},"author":{"name":"Lisa Ray","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c"},"headline":"On The Spotlight: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR), Yahoo! Inc. (NASDAQ:YHOO)","datePublished":"2014-02-25T15:01:20+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo-15957"},"wordCount":380,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo-15957#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Ariad-Pharmaceuticals-Inc.jpg","keywords":["Ariad Pharmaceuticals Inc. (NASDAQ:ARIA)","NASDAQ:ARIA","NASDAQ:YHOO","NYSE:PBR","Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR)","Yahoo! Inc (NASDAQ:YHOO)"],"articleSection":["Business"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo-15957#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo-15957","url":"https:\/\/cablemanpro.com\/wallstreetpr\/on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo-15957","name":"On The Spotlight: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR), Yahoo! Inc. (NASDAQ:YHOO) - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo-15957#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo-15957#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Ariad-Pharmaceuticals-Inc.jpg","datePublished":"2014-02-25T15:01:20+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo-15957#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo-15957"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo-15957#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Ariad-Pharmaceuticals-Inc.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/02\/Ariad-Pharmaceuticals-Inc.jpg","width":1024,"height":709},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/on-the-spotlight-ariad-pharmaceuticals-inc-nasdaqaria-petroleo-brasileiro-petrobras-sa-adr-nysepbr-yahoo-inc-nasdaqyhoo-15957#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"On The Spotlight: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR), Yahoo! Inc. (NASDAQ:YHOO)"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c","name":"Lisa Ray","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png","caption":"Lisa Ray"},"description":"Lisa has a Bachelor of Arts in journalism from Purdue University and 3 years of experience in the publishing field.","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/linsay-thomas"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/15957","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=15957"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/15957\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/14450"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=15957"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=15957"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=15957"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=15957"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}